Novocure is a global oncology company developing a proprietary platform technology called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in multiple solid tumor types. For additional information about the company, please visit www.novocure.com or follow us at www.twitter.com/novocure.
195 Commerce Way
Portsmouth, NH 03801